These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients. Sun J, Zhang J, Lu J, Gao J, Ren X, Teng L, Duan H, Lin Y, Li X, Zhang B, Liang Z. PLoS One; 2016 Aug; 11(4):e0153319. PubMed ID: 27064992 [Abstract] [Full Text] [Related]
16. Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations. Yu PC, Tan LC, Zhu XL, Shi X, Chernikov R, Semenov A, Zhang L, Ma B, Wang Y, Zhou XY, Ji QH, Wei WJ, Wang YL. Endocr Pract; 2021 Jul; 27(7):698-705. PubMed ID: 33515759 [Abstract] [Full Text] [Related]
17. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Gandolfi G, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A, Sancisi V. Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906 [Abstract] [Full Text] [Related]